Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abraxane and Nexavar in Advanced Breast Cancer
NCT00607438Phase 2Terminated
- Sponsor
- Veeda Lifesciences
- Start
- Sep 2007
- Primary completion
- May 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of paclitaxel, sorafenib in breast cancer, sponsored by Veeda Lifesciences. Started Sep 2007; status: terminated.
02
Drugs
paclitaxelsorafenib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00607438.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00607438.